(Q39508242)

English

Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study

scientific article published on April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

type 2 diabetes

0 references

fatty liver disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

author name string

Sung Keun Park

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Mi Hae Seo

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ho Cheol Shin

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Jae-Hong Ryoo

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

1 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1378-1383

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Nonalcoholic fatty liver disease and vascular risk

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Alanine aminotransferase, gamma-glutamyltransferase (GGT) and all-cause mortality: results from a population-based Danish twins study alanine aminotransferase, GGT and mortality in elderly twins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Standards of medical care in diabetes--2010.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Pancreatic fat content and beta-cell function in men with and without type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Liver fat in the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Lipotoxic diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

21 January 2018

Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26183

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.26183

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

release_nrcqocu2zvd2pgqd42uus636ay

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39508242&oldid=1833047113"